NCT05633953View on ClinicalTrials.gov

Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome

CompletedOBSERVATIONAL

Enrollment

103

Participants

Timeline

Start Date

January 16, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 30, 2023

Conditions

Cushing's Syndrome

Interventions

DRUG

Osilodrostat

oral administration

Trial Locations (1)

33604

Hôpital Haut-Lévèque, Pessac

All Listed Sponsors

lead

RECORDATI GROUP

INDUSTRY